In collaboration with Center for Alternatives to Animal Testing (CAAT), ToxMinds conducted a 2-day hands-on training on the use of in silico tools in wider context of chemical hazard assessment.
ToxMinds developed the technical argumentation and science advocacy strategy to prevent an onerous, scientifically unjustified classification & labeling (CLH) proposal
ToxMinds established, in line with EMA guidance, permitted daily exposures for more than 30 active pharmaceutical ingredients to allow managing any API residues in case of shared facility manufacturing arrangement.
ToxMinds assessed consumer exposures and risks associated with the release of volatile organic compounds, including benzene, formaldehyde and naphthalene from scented candles.
ToxMinds was tasked by a petrochemical company to assess the toxicological hazard of and derive MRLs for non-intentionally added substances in a food contact polymer.
ToxMinds is a key resource to a major multinational biopharmaceutical company on the safety assessment of extractables & leachables and manufacturing impurities ending up in the medicinal product.
ToxMinds supported the acquisition of a biocidal product line by a multinational consumer product company by demonstrating the safety of the products for children and adults under in-use conditions.
ToxMinds supports a large, multinational cosmetic product manufacturer in prioritising new molecules for use in cosmetic applications from a consumer safety point of view.
ToxMinds supported a large multinational consumer product company in the context of an internal chemical safety review programme by developing standardised hazard assessments.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok